Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS

Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
Drug Metabolism and Disposition March 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212
Erin E. Bessette
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Fasco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian T. Pentecost
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence S. Kaminsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 33 no. 3 312-320
DOI 
https://doi.org/10.1124/dmd.104.002212
PubMed 
15576448

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received September 9, 2004
  • Accepted November 30, 2004
  • Published online February 14, 2005.

Article Versions

  • Earlier version (December 2, 2004 - 06:48).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Erin E. Bessette,
  2. Michael J. Fasco,
  3. Brian T. Pentecost and
  4. Laurence S. Kaminsky
  1. New York State Department of Health, Wadsworth Center (M.J.F., B.T.P., L.S.K.), Albany, New York; and Department of Environmental Health and Toxicology, University at Albany, State University of New York (E.E.B., M.J.F., B.T.P., L.S.K.), Albany, New York
  1. Address correspondence to:
    Dr. Laurence S. Kaminsky, New York State Department of Health, Wadsworth Center, PO Box 509, Albany, NY 12201-0509. E-mail: kaminsky{at}wadsworth.org
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20170276
Sep 20171154
Oct 20173266
Nov 20170275
Dec 20171130
Jan 20180192
Feb 20181103
Mar 2018174
Apr 201811710
May 20180108
Jun 20180117
Jul 2018084
Aug 2018074
Sep 2018030
Oct 20180303
Nov 20181436
Dec 20183371
Jan 20194400
Feb 20195350
Mar 20192201
Apr 20192800
May 2019900
Jun 2019405
Jul 20191010
Aug 20191822
Oct 20191111
Nov 20192011
Dec 20191131
Jan 20201500
Feb 2020812
Mar 2020900
May 2020500
Jun 2020700
Jul 20201000
Aug 2020513
Sep 2020800
Oct 20201031
Nov 20201700
Dec 20201610
Jan 20211241
Feb 2021731
Mar 20211810
Apr 2021720
May 20213030
Jun 20211610
Jul 20211310
Aug 2021630
Sep 2021910
Oct 2021920
Nov 20211210
Dec 20211610
Jan 2022610
Feb 20221110
Mar 20221800
Apr 20222960
May 20221310
Jun 20222710
Jul 20221321
Aug 20221310
Sep 20221911
Oct 20221310
Nov 20221610
Dec 20221810
Jan 20233831
Feb 20231220
Mar 20232010

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (3)
Drug Metabolism and Disposition
Vol. 33, Issue 3
1 Mar 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS

Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
Drug Metabolism and Disposition March 1, 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS

Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
Drug Metabolism and Disposition March 1, 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Antibiotics Induce Changes in the Expression of Rat DPGs
  • Metabolism of Efavirenz by P450s and UGTs in the Brain
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics